Fate Therapeutics
Clinical trials sponsored by Fate Therapeutics, explained in plain language.
-
Off-the-Shelf cell therapy takes on Hard-to-Treat cancers
Disease control Recruiting nowThis early-phase study tests a ready-made CAR T-cell therapy called FT825, given with or without antibody drugs, for people with advanced HER2-positive or other solid tumors. The main goals are to check safety and find the right dose. About 351 participants will join, and the the…
Phase: PHASE1 • Sponsor: Fate Therapeutics • Aim: Disease control
Last updated Jun 08, 2026 13:11 UTC
-
Off-the-Shelf immune cells take on Hard-to-Treat cancers
Disease control Recruiting nowThis early-stage study tests a new cancer treatment called FT836, a type of immune cell that is made in a lab and ready to use (off-the-shelf). It is given to people with advanced solid tumors like lung, colorectal, breast, ovarian, endometrial, or head and neck cancers that have…
Phase: PHASE1 • Sponsor: Fate Therapeutics • Aim: Disease control
Last updated Jun 01, 2026 17:55 UTC